Company working on multiple levers to boost growth over the next three to five years
Company increasing the scope of business in chronic therapies
Company enhancing its presence in met metro/Tier-I cities
Expect a 16% earnings CAGR for MANKIND over FY24-27
Value MANKIND at 40x12M forward earnings to arrive at a TP of INR 2,650
Initiate coverage with a BUY rating (Source: ETNOW)
Comments
Post a Comment